Skip to main content
David Munn, MD, Pediatric Hematology & Oncology, Augusta, GA

DavidH.MunnMD

Pediatric Hematology & Oncology Augusta, GA

Professor, Pediatrics, Medical College of Georgia at Georgia Health Sciences University

Are you Dr. Munn?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 44 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1120 15th St
    Augusta, GA 30912
    Phone+1 706-721-3626
    Fax+1 706-721-2643

Summary

  • Dr. David Munn, MD is a pediatric hematologist/oncologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia. He is a Professor at Medical College of Georgia at Georgia Health Sciences University.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1987 - 1990
  • Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens Hospital
    Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1984 - 1987
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 1984

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1990 - 2015

Publications & Presentations

PubMed

Press Mentions

  • Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: Research
    Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: ResearchApril 25th, 2023
  • Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain Tumors
    Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain TumorsApril 25th, 2023
  • Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of Psoriasis
    Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of PsoriasisFebruary 28th, 2022
  • Join now to see all

Grant Support

  • Ido-Mediated Immune Regulation In Established TumorsNational Cancer Institute2010–2012
  • Role Of IDO MalignancyNational Cancer Institute2010–2011
  • Ido-Expressing Immunoregulatory Dendritic CellsNational Cancer Institute2010–2011
  • Role Of IDO MalignancyNational Cancer Institute2007–2009
  • Ido-Expressing Plasmacytoid Dendritic Cells And TumorsNational Cancer Institute2005–2009
  • Ido-Expressing Immunoregulatory Dendritic CellsNational Cancer Institute2003–2009
  • Role Of IDO In MalignancyNational Cancer Institute2003–2006
  • Macrophage Mediated Immunoregulation VIA TryptophanNational Heart, Lung, And Blood Institute1999–2002
  • Inhibition Of T Cells By Tryptophan DegradationNational Institute Of Allergy And Infectious Diseases1998–1999
  • Regulation Of Macrophage ApoptosisNational Heart, Lung, And Blood Institute1995–1997